Skip to Content

Join the 'Kengreal' group to help and get support from people like you.

Kengreal News

Anti-Clotting Drug Approved For Angioplasty

Posted 22 Jun 2015 by Drugs.com

MONDAY, June 22, 2015 – Kengreal (cangrelor) has been approved by the U.S. Food and Drug Administration to prevent blood clots from forming during angioplasty. Angioplasty involves inflating a balloon inside a clogged artery to improve blood flow. This is typically followed by insertion of a stent, a small mesh tube designed to keep the artery open. Some 500,000 people in the United States have ...

FDA Approves Antiplatelet Agent Kengreal (cangrelor) as Adjunct to Percutaneous Coronary Intervention

Posted 22 Jun 2015 by Drugs.com

June 22, 2015 – The U.S. Food and Drug Administration today approved Kengreal (cangrelor), an intravenous antiplatelet drug that prevents formation of harmful blood clots in the coronary arteries, the blood vessels that supply blood to the heart. It is approved for adult patients undergoing percutaneous coronary intervention (PCI), a procedure used to open a blocked or narrowed coronary artery ...

Ask a Question

Further Information

Related Condition Support Groups

Percutaneous Coronary Intervention

Kengreal Patient Information at Drugs.com